Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cor Therapeutics Inc. (CORR) -- Ignore unavailable to you. Want to Upgrade?

To: aknahow who wrote (341)	1/24/1999 1:24:00 AM
From: aknahow	Read Replies (1) \| Respond to of 712

From Searles site, definition/description of the drugs recently dropped. Posted for future reference. Xemilofiban An orally active anti-platelet agent (GPIIb/IIIa receptor antagonist) designed for acute/short-term use in preventing thrombotic complications (blood-clot formation) following percutaneous coronary angioplasty (a surgical treatment for clearing blocked arteries). Orbofiban Acetate An orally active anti-platelet agent (GPIIb/IIIa receptor antagonist) designed for long-term use in treating unstable angina (chest pain) and prevention of second thrombotic events (blood-clot formation).